Inflammatory response associated with pulmonary complications in non-HIV immunocompromised patients

Thorax

Volumn 59, Issue 12, 2004, Pages 1081-1088

  Agusti C ^b   Rano A ^c   Rovira, M ^b   Filella, X ^b   Benito, N ^b   Moreno, A ^b   Torres, A ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Althaia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BRONCHOSCOPY; DIAGNOSTIC TEST; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFLAMMATION; LUNG COMPLICATION; LUNG FLUID; LUNG LAVAGE; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; BACTERIAL INFECTIONS; BRONCHOALVEOLAR LAVAGE FLUID; C-REACTIVE PROTEIN; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INTERLEUKINS; LUNG DISEASES; MALE; MIDDLE AGED; NEUTROPHILS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTORS;

EID: 9644281073     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2004.030551     Document Type: Article

References (28)

1. Poe RH, Wahl GW, Qazi R, et al. Predictors of mortality in the immunocompromised patients with pulmonary infiltrates. Arch Intern Med 1986;146:1304-8.
2. Stevens DL. Cytokines: an updated compendium. Curr Opin Infect Dis 1995;8:175-80.
3. Dinarello CA. Proinflammatory and anti-inflammatory cytokines mediators in the pathogenesis of sheptic shock. Chest 1997;112(Suppl 6):321-9.
4. Glynn P, Coakley R, Kilgallen I, et al. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax 1999;54:51-5.
5. Taniguchi T, Koido Y, Aiboshi J, et al. A change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 1999;27:1262-4.
6. Antunes G, Evans SA, Lordan JL, et al. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur Respir J 2002;20:990-5.
7. Smith RP, Lipworfh BJ, Cree IA, et al. C-reactive protein: a clinical marker in community-acquired pneumonia. Chest 1995;108:1288-91.
8. Montón C, Torres A, El-Ebiary M, et al. Cytokine expression in severe pneumonia: a bronchoalveolor study. Crit Care Med 1999;27:1745-53.
9. Rañó A, Agustí C, Jiménez P, et al. Pulmonary infiltrates in non-HIV immunocompromised patients. A diagnostic approach using non-invasive and bronchoscopic procedures. Thorax 2001;56:379-87.
10. Rañó A, Agustí C, Benito N, et al. Prognostic factors of non-HIV immunocompromised patients with pulmonary infiltrates. Chest 2002;122:253-61.
11. Knouss W, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
12. Angrill J, Agustí C, Celis R, et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med 2001;164:1628-32.
13. Bauer TT, Montón C, Torres A, et al. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 2000;55:46-52.
14. Lien E, Ingalls R. Toll-like receptors. Crit Care Med 2002;30:S1-11.
15. Groeneveld ABJ, Tacx AN, Bossink AWJ, et al. Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection. Clin Immunol 2003;106:106-15.
16. Kragsbjerg P, Holmberg H, Vikerfors T. Dynamics of blood cytokine concentrations in patients with bacteremic infections. Scand J Infect Dis 1996;28:391-8.
17. Agusti C, Rañó A, Filella X, et al. pulmonary infiltrates in patients receiving long-term glucocorticoid treatment: etiology, prognostic factors and associated inflammatory response. Chest 2003;123:488-98.
18. Min CK, Lee WY, Min DJ, et al. The kinetics of circulating cytokines including IL-6, TNF-α, IL-8 and IL-10 following allogenic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;28:935-40.
19. Agustí C, Torres A. Dying from pneumonia: which gene is the culprit? Crit Care Med 2004;32:1225-6.
20. Ranieri VM, Suter PM, Tortorella C. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999;282:54-6.
21. Nelson S, Mason CM, Kolls J, et al. Pathophysiology of pneumonia. Clin Chest Med 1995;16:1-12.
22. Toikka P, Irjala K, Juven T, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis 2000;19:598-602.
23. Bonten M, Froon A, Gaillard C, et al. The systemic inflammatory response in the development of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997;156:1105-13.
24. Tuomanen EI, Austrian R, Masure HR. Pathogenesis of pneumococcal infection. N Engl J Med 1995;323:1280-4.
25. Jagger MP, Huo Z, Riches PG. Inflammatory cytokine (interleukin-6 and tumour necrosis factor alpha) release in a human whole blood system in response to Streptococcus pneumoniae serotype 14 and its capsular polysaccharide. Clin Exp Immunol 2002;130:467-74.
26. Dehoux MS, Boutten A, Ostinelli J, et al. Compartmentalized cytokine production within the human lung in the unilateral pneumonia. Am J Respir Crit Care Med 1994;150:710-6.
27. Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 2002;30:S58-63.
28. Bonfield TL, Panuska JR, Konstan MW, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995;152:2111-8.